plant, in three independent experiments examining a total of 33 mice, in most recipients of SCF/IL-Gprestimulated and infected bone marrow cells, the expression of human enzyme was higher than IL-3/ IL-6 mice. Southern blot analysis of DNA from hematopoietic tissues from these same mice prepared at least 4 months posttransplantation also demonstrated a higher infection efficiency of HSC as measured by proviral integration patterns and genome copy number analysis. These results suggest that the higher level of hADA expression seen in mice receiving marrow prestimulated with SCFIIL-6 before retroviral infection is due t o more efficient infection of reconstituting HSC. Other growth factor combinations were also studied; however, prestimulation with SCF/ IL-6 or IL-3/IL-6 appeared optimal. Using retroviralmediated gene transfer and viral integration patterns, Steel factor (SCF) in combination with IL-6 appears t o increase the survival and self-renewal of reconstituting hematopoietic stem cells and proves useful in effecting expression of foreign genes in transplant recipients. Such pretreatment may also be useful in the application of retroviral transfer methods t o human cells. 0 1992 by The American Society of Hematology.
reconstitution requires maintenance of self-renewal capacity in the donor cell population. Pretreatment of donor animals with 5-fluorouracil (5-FU) facilitates retroviral gene transfer into HSC, presumably by promoting cycling of HSC in response to elimination of committed progenit o r~.~,~ Our laboratory has previously shown that interleukin-3 (IL-3) pretreatment in vitro of donor bone marrow cells from 5-FU-treated animals further improves retroviral gene transfer into colony-forming unit-spleen (CFU-SI2) and into reconstituting HSC? Subsequently, Bodine et all0 and our laboratoryll have observed additional improvement in gene transfer efficiency with the combination of IL-3/IL-6 during prestimulation. The optimal protocol for in vitro culture and infection of the murine bone marrow cells appears to be 48-hour prestimulation with IL-3/IL-6 followed by a 48-hour cocultivation with the retroviral producer cells with continued IL-3/IL-6 exposure. However, not all reconstituting HSC are transduced with this combination of cytokines and this inefficiency of infection remains a serious limitation to the application of retroviral technology to larger species. The newly isolated product of the Steel gene (Steel factor or stem cell factor [SCF],12 also known as mast cell growth factor [MGF],13 and kit ligand [KL]14) has a proliferative effect in synergy with several cytokines on hematopoietic stem and progenitor cell populations.15-17 In an effort to further improve the efficiency of retroviral-mediated gene transfer into reconstituting HSC, we have examined the effects of Steel factor when used alone or in combination with other cytokines for prestimulation of bone marrow cells before retroviral infection. We report the successful use of SCF to further improve retroviral-mediated gene transfer into HSC.
EFFECT OF STEEL FACTOR ON GENE TRANSFER OF ADA
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MATERIALS AND METHODS
Retroviral vectors and virus-producing cell lines. The ZipPGK-ADA retrovirus was constructed as described previously1* and contains the human ADA cDNA expressed off the human X chromosome phosphoglycerate kinase promoter in the sense orientation (relative to the retroviral5' long terminal repeat [LTR] ). A unique EcoRI restriction site is located immediately 5' to the PGK promoter. EcoRV restriction sites are present in each LTR. Therefore, EcoRI digestion of genomic DNA yields unique fragments for each retroviral integration site, and EcoRV digestion yields a single provirus-sized fragment. We have generated a higher-titer producer clone than that used in our previous rep o r t~.~,~~,~* The ZipPGK-ADA and pMC1Neo-pA+ (Stratagene, La Jolla, CA) plasmids were cotransfected (1O:l ratio) into GP + E8619 (helper-free producer cell line for ecotropic retrovirus) by calcium phosphate precipitation, and clones were selected in 0.8 mg/mL G418 (dry powder; GIBCO, Grand Island, NY) for expression of neomycin phosphotransferase. Fifty clones were titered by infecting NIH/3T3 cells with producer supernatants, then selecting the infected cells for overexpression of ADA in 4 mmol/L xylofuranosyl arabinoside (Xyl-A) and 4 nmol/L deoxycoformycin (dCF) (both supplied by Drug Synthesis and Chemistry Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD). The highest-titer clone, EPhA10-15, produces 5 X lo3 Xyl-A/dCF resistance CFU/mL. This clone was then cocultured for 10 days with an equal number of GP + envAml2 cellsm (amphotropic retroviral producer cell line) for "ping-pong" amplification of titer.21 The ecotropic producer cell line was again subcloned by selection in 0.8 mg/mL G418, and 10 amplified clones were titered as above. The highest-titer amplified clone, aEPhA5, produced 5 x 104 Xyl-AldCF-resistant CFU/mL and was used in all experiments. No helper virus was detected when supernatant from Xyl-A/dCF-resistant, aEPhA5-infected NIH/3T3 passaged for 4 weeks was titered for Xyl-A/dCF resistance CFU as above. Producer cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% calf serum, penicillin 100 U/mL, and streptomycin 100 kg/mL (all GIBCO). For use in infecting bone marrow cells by cocultivation, aEPhA5 cells were treated with mitomycin-(= (Sigma, St Louis, MO) 5 kg/mL for 2 hours, then trypsinized, washed twice in fresh media, and plated at approximately 3 X 106 cells per plate onto 10-cm tissue culture plates immediately pretreated with 0.1% gelatin (Sigma). The mitomycin-C-treated cells were overlaid with bone marrow cells the following day. Retroviral titer was stable for at least 3 days after mitomycin-C treatment.
Bone marrow cells were harvested by flushing tibias and femurs of 8-to 10-week-old C3H/HeJ male mice (Jackson Laboratories, Bar Harbor, ME) 48 hours after intraperitoneal injection with 5-FU 150 mg/kg body weight (SoloPak Laboratories, Franklin Park, IL). At harvest, each mouse yielded approximately 1 x lo7 nucleated cells bone marrow cells (FUzBM)/2 hindlimbs. Bone marrow cells were prestimulated for 48 hours at a concentration of 1 X lo6 nucleated cells/mL in a-modified Eagle's medium (a-MEM), supplemented by 20% fetal calf serum (prescreened to support murine progenitor cell growth) (Sigma), penicillin 100 U/mL, streptomycin 100 pg/mL, and hematopoietic growth factors in 10 mL on IO-cm petri dishes (Falcon, Lincoln Park, NJ). After vigorous pipetting to remove cells loosely adherent to the plastic, the medium with the nonadherant cells was then overlaid onto mitomycin-C-treated aEPhA5 producer cells for 48 hours in the presence of 4 pg/mL polybrene (Aldrich, Milwaukee, WI). After vigorous pipetting to remove cells loosely adherent to the producer Retroviral infection and bone marrow transplantation. cell monolayer, nonadherent cells were harvested and injected into lethally irradiated syngeneic recipients (cesium 137, 11.5 Gy, split-dose, with a minimum of 3 hours between doses). For spleen colonies,22 0.2 to 2.0 X 105 nonadherent cells were injected into each irradiated recipient. These animals were killed 12 to 14 days later and individual CFU-S-derived spleen colonies counted. For long-term reconstitution, all the nonadherant cells from one plate were injected into one recipient. Each growth factor combination used was repeated at least once, with three animals per group per experiment.
Where indicated, hematopoietic growth factors were used at the following concentrations: recombinant murine IL-3 (Amgen Biologicals, Thousand Oaks, CA) at 100 U/mL, recombinant human IL-6 (Amgen Biologicals, or Genzyme, Cambridge, MA) at 50 to 100 U/mL, recombinant rat SCF164, (Amgen Biologicals) at 100 ng/ mL, and recombinant murine IL-la (kindly supplied by HoffmannLaRoche, Nutley, NJ) at 5 x lo3 U/mL. In some experiments, for CFU-S determinations only, IL-3 was used in the form of 10% WEHI-3Bxonditioned medium.
The expression of transduced human ADA cDNA was analyzed as previously described.'* Briefly, 25 )I.L heparinized peripheral blood was added to 75 pL lysis buffer (5 mmol/L K2HPO4/1 mmol/L EDTA), freeze-thawed twice, and kept at -20°C until enzyme analysis was performed. Lysate supernatants were loaded onto Titan 111 cellulose-acetate strips presoaked in Supra Heme running buffer (both from Helena Laboratories, Beaumont, TX) and ADA isoenzymes were separated by electrophoresis at 290 V. Enzyme activity was detected by sandwiching the cellulose acetate plate to a nitrocellulose filter presoaked with a solution containing xanthine oxidase (0.06 U/mL) and nucleoside phosphorylase (15 kg/mL) (both from Boehringer Mannheim, Indianapolis, IN), adenosine (2 mg/mL), dimenthyethiazol diphenyltetrazolium bromide (0.5 mg/ mL), and phenazine methosulphate (0.1 mg/mL) (all from Sigma) in 50 mmol/L phosphate buffer, pH 7.5, at 37°C for 12 to 15 minutes.
DNA was prepared from spleen, thymus, and bone marrow of dead animals using a DNA extraction kit (Stratagene, La Jolla, CA) according to manufacturer's recommendations. For Southern analysis, DNA was digested with EcoRV (for proviral structure) or EcoRI (for proviral integration patterns).
Digested DNA was electrophoresed on a 3-mm thick, 1% agarose vertical gel, transferred to nylon membrane (Magnagraph; Micron Separations, Westboro, MA) by pressure-blotting, and hybridized to a 32P-labeled NcoZlHinfI fragment of human ADA cDNA. As a control, stripped blots were rehybridized with a 32P-labeled 300-bp reverse-transcriptase/polymerase chain reaction (PCR)-generated fragment from the 5' end of the murine @-actin cDNA. Prehybridization, hybridization, and posthybridization washes were performed according to the membrane manufacturer's recommendations. For slot-blot analysis, 10 pg DNA was applied to the filter, and the final wash after hADA-cDNA hybridization was performed in 0 . 1~ SSC (lx SSC = 0.15 mol/L NaCl + 0.015 mol/L sodium citrate)/l.O% sodium dodecyl sulfate (SDS) at 70°C for 30 minutes to avoid cross-hybridization with endogenous murine ADA sequences. DNA from the EPhAlO15 producer line was used as a positive control, as it contains four proviral integrations of the hADA cDNA. Filters were exposed to a phosphorimager screen and quantified using ImageQuant software (Molecular Dynamics, Sunnyvale, CA). Display windows were chosen to accurately reflect the relative signal intensities of the bands.
Expression of human ADA in murine peripheral blood. 
DNA analysis.
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RESULTS
We evaluated the effect of SCF during prestimulation and retroviral infection on the CFU-S12 compartment as a possible approximation of the effect of SCF on the reconstituting HSC. Bone marrow cells harvested from cocultures on retroviral producer cells were injected at limiting dilution into lethally irradiated mice for CFU-S~Z determination. The results are shown in Table 1 . In numerous prior experiments, we have observed CFU-SI2 content of FU2BM cultured for 4 days (2 days "mock" prestimulation followed by 2 days cocultivation) in the absence of added hematopoietic growth factors to be less than or equal to 1/1@ cells injected (data not shown). This result was confirmed in experiment 1. The addition of 50 to 100 U/mL recombinant human (rH)IL-6) led to increased numbers of CFU-Slz (4 to 9/1@ injected cells) after this same culture period. Addition of murine IL-3 (added either as 10% WHI-3B-conditioned medium or in recombinant form) to IL-6 during prestimulation and infection increased the CFU-SI2 content over that seen with IL-6 alone only slightly (5 to 20/1@ injected cells). However, the addition of recombinant rat (rr)SCF to IG6 in the prestimulation and coculture medium consistently led to a threefold to fivefold increase in CFU-S12 numbers after in vitro manipulations compared with IL-6 alone or in combination with IL-3 (18 to 58 CFU-S/105 injected cells). In simultaneous experiments, IL-6/SCF was superior to IL-3 alone (experiments 1 and 4) or IL-3/SCF (experiment 1) in supporting CFU-S12 survival.
In some of the experiments above, 10% WEHI3B-conditioned medium used as the source of murine IL-3 provided only 2 to 10 U/mL IL-3 activity in the media (data not shown). Subsequent experiments replaced WEHI3B-conditioned media with recombinant murine IL-3 (50 to 100 U/mL) during prestimulation and infection. Again, the combination of SCF + IL-6 exposure during the 96 hours of in vitro manipulation yielded a greater CFU-S12 recovery Effect of SCF on CFU-SI2 survival in vitro.
than seen with either IL-6 alone or IL-3 + IL-6 (9.5 k 3.3 CFU-S12/1@ cells injected [mean k SD] with IL-6 alone, 20.3 f 4.7 with IL-3/IL-6, and 58 f 2.8 with SCF/ILd, experiment 4). Recombinant murine IL-3 (100 U/mL) was used in all experiments (reported below) for long-term reconstitution.
Long-tem expression of human ADA: effect of SCF on retroviral infection of murine reconstituting HSC. Our laboratory and other investigators have previously observed that the long-term expression of hADA in the peripheral blood of mice transplanted with bone marrow cells infected with the simplified PGK-ADA vector parallels the efficiency of retroviral infection of reconstituting HSC.9,U,24 Since optimal infection efficiency of HSC has been previously demonstrated with this vector using prestimulation of bone marrow with IL-3/IL-6, this combination was used for comparison in all experiments. Prestimulated cells were subsequently cocultured with the same retroviral producer cell line aEphAS, for 48 hours in the continued presence of the same cytokine. The recovely of cells after 48 hours of cocultivation ranged from a low of 15% to a high of 50% of input cells. This recovery was not different between cytokine groups, nor did it correlate with long-term expression data, a finding which confirms the lack of correlation between gene transduction in short-lived hematopoietic cells and reconstituting HSC. The differing effects of cytokine stimulation on total cell number in subsequent long-term expression experiments were controlled for by injecting identical femur equivalents (ie, starting cell numbers) into each mouse after cocultivation. Table 2 summarizes the expression of hADA in the peripheral blood following transplantation of bone marrow after prestimulation and PGK-ADA vector transduction of FU2BM in the presence of the indicated growth factors. All recipient mice expressed easily detectable levels of hADA at 1 month posttransplant, regardless of the cytokine combinations used during prestimulation and infection. However, when IL-6 alone, IL-1/SCF, or IL-l/IL-6/SCF was added during in vitro manipulation of the bone marrow, sustained expression of hADA was not observed in some recipient mice. Only one of four mice continued to express detectable hADA at 4 months posttransplant when transplanted with cells prestimulated with IL-6 alone, while five of six IL-1/ SCF mice and three of five IL-l/ILd/SCF mice demonstrated hADA expression at 4 months posttransplantation.
These results are consistent with previous studies from our laboratory and by other investigators demonstrating that expression seen in murine transplant recipients within the first 60 days posttransplantation is not a reliable indicator of HSC t r a n s d~c t i o n .~,~~,~~ In contrast, all mice transplanted However, we consistently observed a higher level of hADA expression in mice transplanted with bone marrow prestimulated with SCF/IL-6 than in mice transplanted with bone prestimulated with any other cytokine combination. Figure 1 shows the expression of hADA in the peripheral blood of cohorts of recipient mice from three independent experiments. In these experiments, six of nine mice receiving bone marrow cells prestimulated with SCF/IL-6 consistently expressed higher levels of hADA than mice transplanted simultaneously with cells prestimulated with IL-3/ IL-6. This result is most obvious in experiment 3 (where the level of hADA expression was lower in all animals, compared with experiments 1 and 2) and hADA is just detectable in IL-3/IL-6 mice, but easily demonstrated in IL-6/SCF mice. In three of nine mice, the level of hADA expression was equivalent between the 1L-3/IL-6 and SCF/IL-6 groups. In no case was the level of hADA expression less in the SCF/IL-6 group than in the IL-3/IL-6 group.
Surprisingly, the addition of a third cytokine (including IL-3) to SCF/IL-6 led to decreased long-term expression of hADA in some experiments (compare hADA in IL3/IL-6/ SCF mice to IL-3/IL-6 and ILd/SCF mice in experiment 2). More consistently, addition of IL-la to IL-6/SCF led to less long-term hADA expression than the IL6/SCF combination. Prestimulation with SCF alone led to detectable long-term hADA expression (4 months posttransplant); however, IL-3 alone or IL-6/SCF led to greater hADA expression than with SCF alone (results of single experiment with 3 mice in each group, data not shown).
DNA anabsis of mice reconstituted with infected bone mamw: eflecr of SCF on proviral content in progeny of infected HSC. Figure 2 shows the DNA analysis of bone marrow from two randomly picked mice in each group of experiment 1 (Fig 1) killed at 6 months posttransplantation. Southern blot analysis of EcoRV-digested DNA prepared from bone marrow cells of the recipicnt animals and probed with hADA cDNA probe shows an intact 2.7-kb hybridizing proviral band in all animals (at arrow), although the hybridizing band in IL-6 mice is only seen with longer 
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-; , . *F -.~ exposure of the autoradiogram. As judged from the signal intensity of this hybridizing band, the proviral copy number is greatest in the DNA of the animals that received SCF/IL-6-prestimulated bone marrow relative to the animals receiving bone marrow prestimulated with IL3/IL-6 or IL-6 alone. Hybridization of the same Southern blot with a probe for f3-actin confirms equivalent loading of the different DNA samples (Fig 2B) . The level of hADA expression seen in the peripheral blood of these mice (Fig  1) correlates with the proviral content of the hematopoietic tissues.
Quantitative slot blot analysis of DNA prepared from bone marrow, spleen, and thymus of these animals is shown in Fig 3. After correction for differences in loading (based on hybridization to p-actin probe), the hybridizing signals were quantified on a phosphorimager, compared with controls, and the proviral copy number calculated, as shown below each slot in Fig 3. Micc receiving SCF/IL-6-pretreated bone marrow had a greater proviral content in all three hematopoietic tissues, including the lymphoid compartment (as reflected by the thymic DNA) than IL-3/IL-6 mice. The average proviral content of all hematopoietic tissues in ILd/SCF mice was 0.58 copies per genome, compared with 0.40 copies per genome in IL-3/ IL-6 mice. In agreement with Fig 2, integrations, reflecting repopulation of the thymus with the progeny of multiple infected stem cell clones (or the progeny of a single stem cell clone which is multiply infected), are seen in the DNA prepared from thymic tissue of mice transplanted with bone marrow prestimulated with SCF/IL-6 (at asterisks). One integration band is noted in the DNA prepared from one mousc in the IL-3/IL6 group, while no integration bands are noted in the IL-6 group, suggesting (together with the slot blot analysis) that the number of progeny derived from transduced stem cells is below the levcl of detection of this analysis. DNA analysis of hematopoietic tissues from mice shown in Fig 1, experiment 2, confirmed the correlation between proviral copy number and peripheral blood hADA expression 6 months posttransplant. Quantitative slot blot analysis again demonstrated higher proviral content in IL-6/SCF mice compared with IL-3/IL-6 mice (data not shown). These data are consistent with those obtained by a number of investigators, which show hematopoiesis following bone marrow transplantation is oligoclonal when analyzed by retroviral integration patterns.
DISCUSSION
Development of recombinant retroviral vectors has allowed the efficient transduction of different mammalian cells, including hematopoietic cells.' Infection of hematopoietic stem cells by recombinant retroviral vectors is dependent on a number of factors, including titer of recombinant virus, cycling status of the target cell population, and specific infection protocol used in vitro, including a period of exposure of bone marrow cells to growth stimulatory factors before retroviral infection (prestimulation).8-10 Hematopoietic stem cell transduction has provided information about stem cell behavior in vivo, and stable expression of the introduced gene sequences in progeny of long-lived and reconstituting stem cells is a necessary requisite for successful application of gene transfer technology to the permanent cure of genetic human diseases affecting bone marrow-derived cells7
Previous studies have demonstrated that the simplified retroviral vector PGK-ADA successfully transduces murine reconstituting HSC with the human ADA cDNA, and that expression of hADA is stable in the majority of mice after full hematopoietic reconstitution with these transduced stem cells.ll The lack of expression of hADA in the minority of mice in these studies was due to the lack of efficient infection of reconstituting HSC by the PGK-ADA virus.g In an effort to improve efficiency of infection of HSC using this recombinant virus, we have used the product of the Steel gene, Steel factor or SCF, in combination with other cytokines during the prestimulation period before retroviral infection.
SCF synergizes with several other cytokines to stimulate the growth of multiple primitive colony types in vitro, including colonies derived from high proliferative potential colony-forming cells (HPP-CFC),12 blast colony-forming cells,% and mixed colony-forming cells (CFU-M~X),~~ and has been shown to increase the number of CFU-S12 during incubation of murine bone marrow cells in vitro?8 Our studies also demonstrate that SCF in combination with IL-6 increases the survival of CFU-Slp during in vitro manipulations associated with retroviral infection. SCF has also been shown to stimulate highly purified human primitive hematopoietic cells (CD34+lin-and CD34+DRVCD15-), again in synergy with other growth factor~?~,~O Previous studies examining the role of Steel factor on hematopoietic cells were performed using in vitro cultures that did not contain adherent stromal cell populations. These studies, using competitive repopulation assays and rhodamine staining to assay stem cell phenotype, have suggested that the activity of Steel factor may be greater on more committed cells rather than reconstituting HSC. 16, 28 In contrast, the studies reported here using expression of retroviral introduced gene sequences, as well as proviral genome copy number and integration patterns, suggest that SCF in combination with IL-6 and in the context of cocultivation with a retroviral producer cell line (stromal cells) affects the survival and proliferation of reconstituting HSC. The stability of expression of hADA and the presence of multiple proviral integration bands on Southern analysis 6 months posttransplantation suggest the division and subsequent survival of reconstituting HSC during the in vitro manipulations required for retroviral infection.
The results of the studies reported here compared with analysis of hematopoietic populations in the absence of stromal cells reported by other investigators also suggests that the hematopoietic microenvironment may play an important role in the maintenance of reconstituting HSC. Previous work by a number of investigators has demonstrated the importance of direct HSC/stromal cell interactions in the maintenance of hematopoiesis in v i t r 0 . 3~~~~ Observations that the product of the Steel gene is present in both membrane bound and secreted forms12J3, 34, 35 and that the Steel-Dickie allele of this locus represents a deletion of the transmembrane domain of the protein product (making an obligate secreted p r~t e i n )~~,~~ (F. Martin and KMZ, unpublished results) suggests a significant role for the presentation of the Steel factor in the context of the microenvironment. Recent studies in our laboratory comparing the effects of membrane-bound versus secreted human SCF confirm this differential affect of presentation of Steel factor on duration of hematopoiesis in vitro. 38 In addition, we have demonstrated that retroviral producer cell lines, such as those used in this study, produce mRNA transcripts encoding both membrane-bound and secreted SCF, although the level of protein expression is quite low.
In summary, the studies reported here demonstrate uniform transduction of reconstituting murine HSC using a simplified retroviral vector and stable expression of human ADA protein in all reconstituted mice following bone marrow transplantation of these transduced HSC into lethally irradiated mice. The use of recombinant SCF during prestimulation of the target HSC improves gene transfer efficiency into a primitive stem cell population and may be useful in the further application of gene transfer methods into the HSC of larger animal species, where the efficiency of gene transfer into long-lived stem cells is still problematic.
